Teri Loxam | Vice President-Investor Relations |
Ken Frazier | Chairman and Chief Executive Officer |
Rob Davis | Chief Financial Officer |
Adam Schechter | President-Global Human Health |
Roger Perlmutter | President-Merck Research Laboratories |
Alex Man | Sanford Bernstein |
David Risinger | Morgan Stanley |
Yan Li | Citi |
Jason Gerberry | Bank of America |
Steve Scala | Cowen |
Seamus Fernandez | Leerink |
Chris Schott | JPMorgan |
Alex Arfaei | BMO Capital Market |
Umer Raffat | Evercore ISI |
Jami Rubin | Goldman Sachs |
Vamil Divan | Credit Suisse |
Good morning. My name is Darla, and I will be your conference operator today. At this time, I would like to welcome everyone to Merck's Fourth Quarter 2017 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.